BIOMAT Database Logo BIOMAT Database Logo

[Statistical results of cobalt therapy in Hodgkin's disease]. 1974

F Bauters, and M T Caulier, and J Mouton, and M Goudemand

UI MeSH Term Description Entries
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D011867 Radioisotope Teletherapy A type of high-energy radiotherapy using a beam of gamma-radiation produced by a radioisotope source encapsulated within a teletherapy unit. Teleradioisotope Therapy,Teletherapy, Radioisotope,Therapy, Teleradioisotope
D012075 Remission, Spontaneous A spontaneous diminution or abatement of a disease over time, without formal treatment. Spontaneous Healing,Spontaneous Regression,Spontaneous Remission,Healing, Spontaneous,Regression, Spontaneous,Spontaneous Healings,Spontaneous Regressions
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003037 Cobalt Radioisotopes Unstable isotopes of cobalt that decay or disintegrate emitting radiation. Co atoms with atomic weights of 54-64, except 59, are radioactive cobalt isotopes. Radioisotopes, Cobalt
D005602 France A country in western Europe bordered by the Atlantic Ocean, the English Channel, the Mediterranean Sea, and the countries of Belgium, Germany, Italy, Spain, Switzerland, the principalities of Andorra and Monaco, and by the duchy of Luxembourg. Its capital is Paris. Corsica,Saint Pierre and Miquelon,Miquelon and Saint Pierre,Miquelon and St. Pierre,St. Pierre and Miquelon
D006689 Hodgkin Disease A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen. Granuloma, Hodgkin,Granuloma, Malignant,Hodgkin Lymphoma,Lymphogranuloma, Malignant,Granuloma, Hodgkin's,Granuloma, Hodgkins,Hodgkin Lymphoma, Adult,Hodgkin's Disease,Hodgkin's Lymphoma,Hodgkins Disease,Lymphocyte Depletion Hodgkin's Lymphoma,Lymphocyte-Rich Classical Hodgkin's Lymphoma,Mixed Cellularity Hodgkin's Lymphoma,Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,Nodular Sclerosing Hodgkin's Lymphoma,Adult Hodgkin Lymphoma,Disease, Hodgkin,Disease, Hodgkin's,Disease, Hodgkins,Hodgkin Granuloma,Hodgkin's Granuloma,Hodgkins Granuloma,Hodgkins Lymphoma,Lymphocyte Rich Classical Hodgkin's Lymphoma,Lymphogranulomas, Malignant,Lymphoma, Hodgkin,Lymphoma, Hodgkin's,Malignant Granuloma,Malignant Granulomas,Malignant Lymphogranuloma,Malignant Lymphogranulomas,Nodular Lymphocyte Predominant Hodgkin's Lymphoma
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

F Bauters, and M T Caulier, and J Mouton, and M Goudemand
[Short-term results of cobalt therapy of Hodgkin's disease].
January 1966, Revue medicale du Moyen-Orient,
F Bauters, and M T Caulier, and J Mouton, and M Goudemand
[Results of therapy in Hodgkin's disease].
November 1990, Deutsche medizinische Wochenschrift (1946),
F Bauters, and M T Caulier, and J Mouton, and M Goudemand
Results of therapy in Hodgkin's disease.
September 1958, Annals of the New York Academy of Sciences,
F Bauters, and M T Caulier, and J Mouton, and M Goudemand
[Letter: Mediastinal cobalt therapy for Hodgkin's disease. Thoracic complications].
March 1975, La Nouvelle presse medicale,
F Bauters, and M T Caulier, and J Mouton, and M Goudemand
Pediatric hodgkin's disease. II. Results of therapy.
May 1976, Cancer,
F Bauters, and M T Caulier, and J Mouton, and M Goudemand
Hodgkin's disease in childhood: therapy results in Argentina.
January 1981, The American journal of pediatric hematology/oncology,
F Bauters, and M T Caulier, and J Mouton, and M Goudemand
[Statistical technic of analysis of the results of radiotherapy of Hodgkin's disease].
January 1966, Nouvelle revue francaise d'hematologie,
F Bauters, and M T Caulier, and J Mouton, and M Goudemand
Cobalt-60 therapy of Hodgkin's disease and the subsequent development of hypothyroidism.
February 1972, Cancer,
F Bauters, and M T Caulier, and J Mouton, and M Goudemand
[Therapy of Hodgkin's lymphomas. Results of the German Hodgkin's Disease Study Group].
February 1988, Onkologie,
F Bauters, and M T Caulier, and J Mouton, and M Goudemand
Hodgkin's disease; a statistical report.
August 1952, Radiology,
Copied contents to your clipboard!